ID   AH130/5A
AC   CVCL_4U53
DR   Wikidata; Q54748764
RX   PubMed=9045901;
CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: ChEBI; CHEBI:76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4367 ! AH130
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
RX   PubMed=9045901; DOI=10.1111/j.1349-7006.1997.tb00306.x;
RA   Wakusawa S., Nakamura S., Miyamoto K.-i.;
RT   "Establishment by adriamycin exposure of multidrug-resistant rat
RT   ascites hepatoma AH130 cells showing low DT-diaphorase activity and
RT   high cross resistance to mitomycins.";
RL   Jpn. J. Cancer Res. 88:88-96(1997).
//